OBI To Enter Cartilage Defect Repair Market; Genzyme Developing Carticel II
This article was originally published in The Gray Sheet
Executive Summary
Osteobiologics, Inc. anticipates an early 2000 510(k) submission to FDA for its Actaeon probe arthroscopic instrument for the minimally invasive evaluation of articulate cartilage.